[Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition]
- PMID: 26923972
[Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition]
Abstract
Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in the form of triglycerides in the hepatocytes. A more severe form of NAFLD with necrosis, inflammation, and fibrosis is called non-alcoholic steatohepatitis (NASH). The liver is located in the center of the body's organ network and acts as a coordinator of glucose and lipid metabolism. Therefore, it is important to perform nutritional therapy of patients with NAFLD/NASH while maintaining the energy balance in the entire body.
Similar articles
-
Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.FASEB J. 2015 Apr;29(4):1564-76. doi: 10.1096/fj.14-264937. Epub 2015 Jan 21. FASEB J. 2015. PMID: 25609431
-
Effect of resveratrol on experimental non-alcoholic steatohepatitis.Pharmacol Res. 2015 May-Jun;95-96:34-41. doi: 10.1016/j.phrs.2015.03.005. Epub 2015 Mar 23. Pharmacol Res. 2015. PMID: 25814186
-
Single-Cell Data Analysis Reveals Critical Hepatic Cells Subpopulations in the Progression of Non-alcoholic Fatty Liver Disease to Non-Alcoholic Steatohepatitis.Comb Chem High Throughput Screen. 2025;28(7):1251-1263. doi: 10.2174/0113862073303213240523095742. Comb Chem High Throughput Screen. 2025. PMID: 38803181
-
Identification of Lipid Species Linked to the Progression of Non-Alcoholic Fatty Liver Disease.Curr Drug Targets. 2015;16(12):1293-300. doi: 10.2174/1389450116666150408103318. Curr Drug Targets. 2015. PMID: 25850622 Review.
-
Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition.Nutrients. 2014 Aug 21;6(8):3303-25. doi: 10.3390/nu6083303. Nutrients. 2014. PMID: 25195642 Free PMC article. Review.
Cited by
-
2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside attenuates methionine and choline-deficient diet-induced non-alcoholic fatty liver disease.Exp Ther Med. 2018 Aug;16(2):1087-1094. doi: 10.3892/etm.2018.6300. Epub 2018 Jun 13. Exp Ther Med. 2018. PMID: 30116360 Free PMC article.
-
Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice.Bioengineered. 2022 Mar;13(3):6750-6766. doi: 10.1080/21655979.2022.2045837. Bioengineered. 2022. PMID: 35246007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical